Abbott Stock In The News

Abbott Laboratories stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Abbott earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
There is far too much social signal, news, headlines, and media speculation about Abbott Laboratories that is available to investors today. That information is available publicly through Abbott media outlets and privately through word of mouth or via Abbott internal channels. However, regardless of the origin, that massive amount of Abbott data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Abbott Laboratories news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Abbott Laboratories relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Abbott Laboratories' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Abbott Laboratories alpha.

Abbott Largest EPS Surprises

Earnings surprises can significantly impact Abbott Laboratories' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2017-04-19
2017-03-310.43040.480.049611 
2015-04-22
2015-03-310.420.470.0511 
2014-04-16
2014-03-310.360.410.0513 
2021-07-22
2021-06-301.01811.170.151914 
2020-07-16
2020-06-300.41630.570.153736 
2022-04-20
2022-03-311.471.730.2617 
View All Earnings Estimates

Abbott Laboratories Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Abbott Laboratories Stock. Current markets are strongly bearish. About 86% of major world exchanges and indexes are down. See today's market update for more information.
nasdaq News
23rd of June 2022
Why Investors Should Focus on Abbotts Medical Devices - Nasdaq
at www.nasdaq.com 
Macroaxis News
14th of June 2022
Payment of 19592 shares by Lisa Earnhardt of Abbott Laboratories subject to Rule 16b-3
at MacroaxisInsider 
news
9th of June 2022
Why Are Abbott Shares Trending 20 percent Lower - TipRanks
at www.tipranks.com 
news
26th of May 2022
Safety Lapses at Abbott Exposes FDAs Incompetence - TipRanks
at www.tipranks.com 
salon News
20th of May 2022
Abbott enriched shareholders with stock buybacks amid deadly outbreak at baby formula plan...
at www.salon.com 
marketwatch News
11th of May 2022
As a shortage worsens, Abbott says it can get baby formula back on store shelves in June -...
at www.marketwatch.com 
news
6th of May 2022
Randel William Woodgrift Sells 24000 Shares of Abbott Laboratories Stock - Defense World
at www.defenseworld.net 
marketwatch News
12th of April 2022
Abbott Laboratories stock underperforms Tuesday when compared to competitors - MarketWatch
at www.marketwatch.com 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Abbott Laboratories without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Earnings Calls Now

   

Earnings Calls

Check upcoming earnings announcements updated hourly across public exchanges
All  Next Launch Module

Pair Trading with Abbott Laboratories

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbott Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbott Laboratories will appreciate offsetting losses from the drop in the long position's value.

Abbott Laboratories Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to Abbott Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbott Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbott Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbott Laboratories to buy it.
The correlation of Abbott Laboratories is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbott Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbott Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abbott Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Abbott Laboratories Backtesting and Abbott Laboratories Hype Analysis. Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try CEO Directory module to screen CEOs from public companies around the world.

Complementary Tools for Abbott Stock analysis

When running Abbott Laboratories price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.37
Market Capitalization
191 B
Quarterly Revenue Growth YOY
0.14
Return On Assets
0.0856
Return On Equity
0.22
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Abbott Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ABT
 Stock
  

USD 109.45  2.48  2.32%   

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Abbott and other traded companies coverage. We help investors stay connected with Abbott headlines for the 29th of June to make an informed investment decision based on correlating the impacts of news items on Abbott Stock performance. Please note that trading solely based on the Abbott Laboratories hype is not for everyone as timely availability and quick action are needed to avoid losses. Net Income Common Stock is likely to drop to about 5.8 B in 2022.
  
Refresh
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Abbott Laboratories headlines in addition to utilizing other, more conventional financial analysis modules. Please continue to Abbott Laboratories Backtesting and Abbott Laboratories Hype Analysis.
Abbott Laboratories' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Abbott Laboratories investors visualize upcoming and past events in order to time the market based on Abbott Laboratories noise-free hype analysis.